Rhythm Pharmaceuticals Inc.(RYTM)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RYTM Rhythm Pharmaceuticals Inc.

交易中 05-02 13:13:13 EDT

64.93

+1.13

+1.77%

最高66.04	最低64.06	成交量12.88万
今开64.06	昨收63.80	日振幅3.10%
总市值41.26亿	流通市值30.69亿	总股本6,354万
成交额842.48万	换手率0.27%	流通股本4,727万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"RYTM","market":"US","secType":"STK","nameCN":"Rhythm Pharmaceuticals Inc.","latestPrice":64.93,"timestamp":1746205987866,"preClose":63.8,"halted":0,"volume":128842,"delay":0,"floatShares":47269998,"shares":63538522,"eps":-4.337586,"marketStatus":"交易中","change":1.13,"latestTime":"05-02 13:13:13 EDT","open":64.06,"high":66.04,"low":64.06,"amount":8424825.058020001,"amplitude":0.031034,"askPrice":65.14,"askSize":95,"bidPrice":64.96,"bidSize":38,"shortable":3,"etf":0,"ttmEps":-4.337586,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1746216000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1507176000000,"exchange":"NASDAQ","adjPreClose":63.8,"preHourTrading":{"tag":"盘前","latestPrice":65,"preClose":63.8,"latestTime":"09:28 EDT","volume":722,"amount":46851.821840000004,"timestamp":1746192480036},"postHourTrading":{"tag":"盘后","latestPrice":63.8,"preClose":63.8,"latestTime":"18:54 EDT","volume":75126,"amount":4792942.18,"timestamp":1746140082272},"volumeRatio":0.475861,"impliedVol":0.4345,"impliedVolPercentile":0.124},"requestUrl":"/m/hq/s/RYTM","defaultTab":"news","newsList":[{"id":"2518276046","title":"Rhythm Pharmaceuticals, Inc.盘中异动 早盘快速下挫5.01%报48.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518276046","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518276046?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:30","pubTimestamp":1741617055,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时30分，Rhythm Pharmaceuticals, Inc.股票出现异动，股价大幅下挫5.01%。Rhythm Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Aeon Biopharma, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Aeon Biopharma, Inc.较为活跃，换手率分别为3457.49%、730.68%、517.45%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.，振幅分别为41.36%、40.33%、40.24%。Rhythm Pharmaceuticals, Inc.公司简介：Rhythm Pharmaceuticals Inc 是一家生物制药公司，从事罕见病治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310223055964044b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310223055964044b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4585","BK4139","RYTM"],"gpt_icon":0},{"id":"2517456009","title":"大摩：假定Rhythm Pharmaceuticals(RYTM.US)增持评级, 目标价由72.00美元调整至72.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517456009","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517456009?lang=zh_cn&edition=full","pubTime":"2025-03-08 01:53","pubTimestamp":1741369983,"startTime":"0","endTime":"0","summary":"大摩：假定Rhythm Pharmaceuticals(RYTM.US)增持评级, 目标价由72.00美元调整至72.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/08015348605007.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["RYTM"],"gpt_icon":0},{"id":"2517404949","title":"Stifel：重申Rhythm Pharmaceuticals(RYTM.US)买入评级, 目标价78.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517404949","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517404949?lang=zh_cn&edition=full","pubTime":"2025-03-06 02:01","pubTimestamp":1741197678,"startTime":"0","endTime":"0","summary":"Stifel：重申Rhythm Pharmaceuticals(RYTM.US)买入评级, 目标价78.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/06020148550854.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["RYTM"],"gpt_icon":0},{"id":"2516480445","title":"Rhythm Pharmaceuticals, Inc.2024财年实现净利润-2.61亿美元，同比减少41.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516480445","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516480445?lang=zh_cn&edition=full","pubTime":"2025-03-03 00:00","pubTimestamp":1740931238,"startTime":"0","endTime":"0","summary":"3月3日，Rhythm Pharmaceuticals, Inc.公布财报，公告显示公司2024财年净利润为-2.61亿美元，同比减少41.08%；其中营业收入为1.30亿美元，同比增加67.89%，每股基本收益为-4.34美元。机构评级：截至2025年3月3日，当前有11家机构对Rhythm Pharmaceuticals, Inc.目标价做出预测，其中目标均价为74.73美元，其中最低目标价为60.00美元，最高目标价为94.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303000058abe4aca5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303000058abe4aca5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RYTM"],"gpt_icon":0},{"id":"2514733235","title":"加拿大投资银行集团：维持Rhythm Pharmaceuticals(RYTM.US)评级，由买入调整至买入评级, 目标价由80.00美元调整至81.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514733235","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514733235?lang=zh_cn&edition=full","pubTime":"2025-02-28 04:11","pubTimestamp":1740687119,"startTime":"0","endTime":"0","summary":"加拿大投资银行集团：维持Rhythm Pharmaceuticals(RYTM.US)评级，由买入调整至买入评级, 目标价由80.00美元调整至81.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/28041148442125.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["RYTM"],"gpt_icon":0},{"id":"1168826920","title":"异动解读 | Rhythm Pharmaceuticals公布2024年Q4财报出色 盘中股价大涨5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1168826920","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168826920?lang=zh_cn&edition=full","pubTime":"2025-02-27 02:06","pubTimestamp":1740593190,"startTime":"0","endTime":"0","summary":"Rhythm Pharmaceuticals Inc. (RYTM)今日盘中大涨5.01%，引起了市场的广泛关注。\n\n公司发布的2024年第四季度财报显示营收实现4183万美元，超出市场预期的3848万美元。公司每股亏损0.72美元，则符合了市场对亏损0.73美元的预期。\n\n从财报数据看，公司营收同比大增72.61%，业绩优于市场预期。因此公司财报出色是导致今日股价上涨的主要原因。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["RYTM"],"gpt_icon":0},{"id":"2514145866","title":"Rhythm Pharmaceuticals, Inc.盘中异动 大幅拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514145866","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514145866?lang=zh_cn&edition=full","pubTime":"2025-02-27 02:05","pubTimestamp":1740593153,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日02时05分，Rhythm Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.00%。Rhythm Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.40%。其相关个股中，Enveric Biosciences, Inc.、Pds Biotechnology Corporation、Renovaro Inc.涨幅较大，Enveric Biosciences, Inc.、Aeon Biopharma, Inc.、Organovo Holdings, Inc.较为活跃，换手率分别为6389.14%、258.52%、239.59%，振幅较大的相关个股有Enveric Biosciences, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Pds Biotechnology Corporation，振幅分别为194.07%、49.18%、44.44%。Rhythm Pharmaceuticals, Inc.公司简介：Rhythm Pharmaceuticals Inc 是一家生物制药公司，从事罕见病治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227020553abde1c3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227020553abde1c3e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RYTM","BK4585","BK4588","BK4139"],"gpt_icon":0},{"id":"2514831857","title":"Rhythm Pharmaceuticals(RYTM.US)：2024年Q4财报实现营收4183万美元，前值为2423.4万美元，预期值为3848万美元；每股收益为-0.72美元，前值为-0.70美元，预期值为-0.73美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514831857","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514831857?lang=zh_cn&edition=full","pubTime":"2025-02-26 20:11","pubTimestamp":1740571870,"startTime":"0","endTime":"0","summary":"Rhythm Pharmaceuticals(RYTM.US)：2024年Q4财报实现营收4183万美元，前值为2423.4万美元，预期值为3848万美元；每股收益为-0.72美元，前值为-0.70美元，预期值为-0.73美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/26201148410993.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["RYTM"],"gpt_icon":0},{"id":"1187635106","title":"Rhythm Pharmaceuticals第四季度每股盈余$(0.72)，符合预期，销售额4183万美元，超出预期3848万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1187635106","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187635106?lang=zh_cn&edition=full","pubTime":"2025-02-26 20:10","pubTimestamp":1740571844,"startTime":"0","endTime":"0","summary":"Rhythm Pharmaceuticals  公布季度每股亏损$，符合分析师一致预期。公司报告季度销售额为4183万美元，超出分析师一致预期的3848万美元，增长8.69%。相比去年同期销售额2423万美元，增加了72.61%。以上内容来自Benzinga Earnings专栏，原文如下：Rhythm Pharmaceuticals  reported quarterly losses of $ per share which met the analyst consensus estimate. This is a 2.86 percent decrease over losses of $ per share from the same period last year.  The company reported quarterly sales of $41.83 million which beat the analyst consensus estimate of $38.48 million by 8.69 percent.  This is a 72.61 percen","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Rhythm Pharmaceuticals第四季度每股盈余$(0.72)，符合预期，销售额4183万美元，超出预期3848万美元","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RYTM"],"gpt_icon":0},{"id":"2514118360","title":"Rhythm Pharmaceuticals, Inc.盘中异动 急速下挫5.04%报51.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514118360","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514118360?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:08","pubTimestamp":1740499725,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时08分，Rhythm Pharmaceuticals, Inc.股票出现异动，股价急速跳水5.04%。Rhythm Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.74%。其相关个股中，Organovo Holdings, Inc.、Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大，Organovo Holdings, Inc.、Gt Biopharma, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为1246.54%、1101.53%、849.54%，振幅较大的相关个股有Organovo Holdings, Inc.、Silexion Therapeutics Corp、Adial Pharmaceuticals, Inc，振幅分别为224.93%、87.83%、64.05%。Rhythm Pharmaceuticals, Inc.公司简介：Rhythm Pharmaceuticals Inc 是一家生物制药公司，从事罕见病治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226000845963007df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226000845963007df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RYTM","BK4588","BK4585"],"gpt_icon":0},{"id":"2505784147","title":"Rhythm Pharmaceuticals, Inc.盘中异动 临近收盘大幅拉升5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505784147","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505784147?lang=zh_cn&edition=full","pubTime":"2025-01-22 04:50","pubTimestamp":1737492623,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日04时50分，Rhythm Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.06%。Rhythm Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.76%。其相关个股中，Dogwood Therapeutics, Inc.、Camp4 Therapeutics Corporation、Channel Therapeutics Corporation涨幅较大，Dogwood Therapeutics, Inc.、Channel Therapeutics Corporation、Dermata Therapeutics, Inc.较为活跃，换手率分别为1753.49%、530.91%、192.36%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Channel Therapeutics Corporation、Revolution Medicines Inc C/Wts 17/12/2026 ，振幅分别为103.72%、96.32%、69.14%。Rhythm Pharmaceuticals, Inc.公司简介：Rhythm Pharmaceuticals Inc 是一家生物制药公司，从事罕见病治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122045024a22aa3f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122045024a22aa3f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","RYTM","BK4588"],"gpt_icon":0},{"id":"2500975669","title":"Rhythm Pharmaceuticals, Inc.盘中异动 早盘快速上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500975669","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500975669?lang=zh_cn&edition=full","pubTime":"2025-01-02 23:29","pubTimestamp":1735831795,"startTime":"0","endTime":"0","summary":"北京时间2025年01月02日23时29分，Rhythm Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.00%。Rhythm Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.90%。其相关个股中，Revelation Biosciences Inc C/Wts 10/01/2027 、Revelation Biosciences, Inc.、Celularity Inc C/Wts 16/07/2026 涨幅较大，Revelation Biosciences, Inc.、知临集团、Onconetix, Inc.较为活跃，换手率分别为1090.54%、110.82%、48.53%，振幅较大的相关个股有Revelation Biosciences, Inc.、Revelation Biosciences Inc C/Wts 10/01/2027 、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为125.57%、98.57%、78.14%。Rhythm Pharmaceuticals, Inc.公司简介：Rhythm Pharmaceuticals Inc 是一家生物制药公司，从事罕见病治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010223295598590957&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010223295598590957&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RYTM","BK4585","BK4139","BK4588"],"gpt_icon":0},{"id":"2492515801","title":"Rhythm Pharmaceuticals, Inc.盘中异动 临近收盘大幅跳水5.02%报53.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492515801","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492515801?lang=zh_cn&edition=full","pubTime":"2024-12-19 04:39","pubTimestamp":1734554366,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日04时39分，Rhythm Pharmaceuticals, Inc.股票出现异动，股价快速跳水5.02%。Rhythm Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为2.80%。其相关个股中，Polyrizon Ltd.、Tc Biopharm  Plc C/Wts 10/02/2028 、Surrozen Inc C/Wts 01/08/2031 涨幅较大，Polyrizon Ltd.、Cognition Therapeutics, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为3229.00%、677.93%、350.85%，振幅较大的相关个股有Polyrizon Ltd.、Cognition Therapeutics, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为227.62%、145.02%、105.17%。Rhythm Pharmaceuticals, Inc.公司简介：Rhythm Pharmaceuticals Inc 是一家生物制药公司，从事罕见病治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121904392695ea5add&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121904392695ea5add&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","RYTM","BK4139","BK4588"],"gpt_icon":0},{"id":"2486503816","title":"Rhythm Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486503816","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486503816?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:33","pubTimestamp":1732545229,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时33分，Rhythm Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.06%。Rhythm Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.06%。其相关个股中，Scholar Rock Holding Corporation、Bridgebio Pharma, Inc.、Citius Pharmaceuticals, Inc.涨幅较大，Cognition Therapeutics, Inc.、木薯科学、Citius Pharmaceuticals, Inc.较为活跃，换手率分别为87.24%、61.67%、38.71%，振幅较大的相关个股有Anixa Biosciences, Inc.、Werewolf Therapeutics, Inc.、Kodiak Sciences Inc，振幅分别为105.47%、105.26%、105.01%。Rhythm Pharmaceuticals, Inc.公司简介：Rhythm Pharmaceuticals Inc 是一家生物制药公司，从事罕见病治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223349a2548d8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223349a2548d8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RYTM","BK4585","BK4588","BK4139"],"gpt_icon":0},{"id":"2483637851","title":"Rhythm Pharmaceuticals, Inc.盘中异动 下午盘急速下挫5.28%报60.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483637851","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483637851?lang=zh_cn&edition=full","pubTime":"2024-11-14 03:45","pubTimestamp":1731527145,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日03时45分，Rhythm Pharmaceuticals, Inc.股票出现波动，股价快速下跌5.28%。Rhythm Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.45%。其相关个股中，Nkgen Biotech Inc C/Wts 31/05/2028、Pulmatrix, Inc.、Calidi Biotherapeutics, Inc.涨幅较大，Elevai Labs, Inc.、Cyclacel Pharmaceuticals, Inc.、Calidi Biotherapeutics, Inc.较为活跃，换手率分别为632.50%、553.73%、165.03%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Pulmatrix, Inc.、Celularity Inc C/Wts 16/07/2026 ，振幅分别为140.00%、86.83%、73.71%。Rhythm Pharmaceuticals, Inc.公司简介：Rhythm Pharmaceuticals Inc 是一家生物制药公司，从事罕见病治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111403454598e42733&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111403454598e42733&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PULM","BK4585","BK4588","BK4007","RYTM"],"gpt_icon":0},{"id":"1182108507","title":"异动解读 | Rhythm Pharmaceuticals股价大涨5.7% 分析师看好公司前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1182108507","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182108507?lang=zh_cn&edition=full","pubTime":"2024-11-11 03:48","pubTimestamp":1731268103,"startTime":"0","endTime":"0","summary":"11月8日,生物制药企业Rhythm Pharmaceuticals Inc. 股价盘中大涨5.7%,报收67.10美元/股。该股近期交投较为活跃,当日换手率为1%,振幅达6.48%。Rhythm Pharmaceuticals最新财报显示,公司实现营收3325万美元,净亏损4364万美元,每股亏损0.73美元,毛利率为88%。这一罕见病缺乏有效治疗方案,Setmelanotide可望成为突破性疗法。Rhythm Pharmaceuticals是一家专注于罕见疾病的生物制药公司,其主要收入来源于美国、德国等地。分析人士认为,在全球市场需求的带动下,Rhythm Pharmaceuticals有望持续扩大经营规模。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | Rhythm Pharmaceuticals股价大涨5.7% 分析师看好公司前景","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["RYTM"],"gpt_icon":0},{"id":"2482397267","title":"Rhythm Pharmaceuticals, Inc.2024财年第三财季实现净利润-43.64百万美元，同比增加1.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482397267","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482397267?lang=zh_cn&edition=full","pubTime":"2024-11-11 00:01","pubTimestamp":1731254501,"startTime":"0","endTime":"0","summary":"11月11日，Rhythm Pharmaceuticals, Inc.公布财报，公告显示公司2024财年第三财季净利润为-43.64百万美元，同比增加1.18%；其中营业收入为33.25百万美元，同比增加47.78%，每股基本收益为-0.73美元。机构评级：截至2024年11月11日，当前有11家机构对Rhythm Pharmaceuticals, Inc.目标价做出预测，其中目标均价为70.27美元，其中最低目标价为58.00美元，最高目标价为84.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111000228abb3637d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111000228abb3637d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RYTM"],"gpt_icon":0},{"id":"2482432147","title":"Rhythm Pharmaceuticals, Inc.盘中异动 快速拉升5.01%报67.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482432147","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482432147?lang=zh_cn&edition=full","pubTime":"2024-11-09 03:42","pubTimestamp":1731094960,"startTime":"0","endTime":"0","summary":"北京时间2024年11月09日03时42分，Rhythm Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.01%。Rhythm Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.20%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Rigel Pharmaceuticals, Inc.、阿诺医药涨幅较大，Elevai Labs, Inc.、Cyclacel Pharmaceuticals, Inc.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为799.63%、118.27%、84.28%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为134.44%、107.20%、87.00%。Rhythm Pharmaceuticals, Inc.公司简介：Rhythm Pharmaceuticals Inc 是一家生物制药公司，从事罕见病治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109034240a2255c2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109034240a2255c2a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RYTM","BK4588","BK4585"],"gpt_icon":0},{"id":"1140892200","title":"异动解读 | Rhythm Pharmaceuticals Inc.最新季报业绩超预期 股价盘中大涨14.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1140892200","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140892200?lang=zh_cn&edition=full","pubTime":"2024-11-06 23:44","pubTimestamp":1730907863,"startTime":"0","endTime":"0","summary":"Rhythm Pharmaceuticals Inc.今日股价盘中大涨14.7%,主要是受到公司最新季度业绩表现优于分析师预期的利好影响。\n\n该公司公布的最新一季度财报数据显示,营收同比增长47.8%至3325万美元,高于市场平均预期水平。尽管公司本季度仍处于亏损状态,但调整后每股亏损73美分,较预期的80美分有所改善。\n\n分析人士认为,Rhythm Pharmaceuticals Inc.本季度业绩表现超出市场预期,主要得益于较高的营收增长以及亏损幅度较预期收窄。这反映了公司在业务拓展和成本管控方面所做出的积极努力,提升了投资者对其未来发展前景的信心,从而推动股价出现大幅上涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["RYTM"],"gpt_icon":0},{"id":"2481899189","title":"Rhythm Pharmaceuticals, Inc.盘中异动 股价大涨8.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481899189","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481899189?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:34","pubTimestamp":1730903657,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时34分，Rhythm Pharmaceuticals, Inc.股票出现波动，股价急速拉升8.89%。Rhythm Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.26%。其相关个股中，Sonnet Biotherapeutics Holdings, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Sonnet Biotherapeutics Holdings, Inc.、Elevai Labs, Inc.、Zyversa Therapeutics, Inc.较为活跃，换手率分别为1070.77%、103.45%、54.59%，振幅较大的相关个股有Lakeshore Biopharma Co., Ltd、Inmed Pharmaceuticals Inc.、Immunitybio, Inc.，振幅分别为107.44%、106.04%、105.49%。Rhythm Pharmaceuticals, Inc.公司简介：Rhythm Pharmaceuticals Inc 是一家生物制药公司，从事罕见病治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622341795bddbf1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622341795bddbf1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","RYTM","BK4139","BK4588"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.rhythmtx.com","stockEarnings":[{"period":"1week","weight":0.0132},{"period":"1month","weight":0.276},{"period":"3month","weight":0.0735},{"period":"6month","weight":0.3018},{"period":"1year","weight":0.5399},{"period":"ytd","weight":0.1397}],"compareEarnings":[{"period":"1week","weight":0.0215},{"period":"1month","weight":-0.0045},{"period":"3month","weight":-0.072},{"period":"6month","weight":-0.022},{"period":"1year","weight":0.1162},{"period":"ytd","weight":-0.0471}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Rhythm Pharmaceuticals, Inc.是一家特拉华州的公司，成立于2013年2月。该公司是一家全球性、商业阶段的生物制药公司，致力于改变患有罕见神经内分泌疾病的患者及其家人的生活。该公司专注于推进黑皮质素-4受体激动剂，包括他们的主要资产IMCIVREE，作为一种精准药物，旨在治疗由罕见的MC4R通路疾病引起的食欲亢进和严重肥胖。","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":-0.053118},{"month":2,"riseRate":0.375,"avgChangeRate":-0.043141},{"month":3,"riseRate":0.125,"avgChangeRate":-0.055987},{"month":4,"riseRate":0.625,"avgChangeRate":0.023443},{"month":5,"riseRate":0.25,"avgChangeRate":-0.057266},{"month":6,"riseRate":0.428571,"avgChangeRate":0.04883},{"month":7,"riseRate":0.428571,"avgChangeRate":0.272148},{"month":8,"riseRate":0.714286,"avgChangeRate":0.243579},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.043398},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.035366},{"month":11,"riseRate":0.875,"avgChangeRate":0.159256},{"month":12,"riseRate":0.625,"avgChangeRate":0.048832}],"exchange":"NASDAQ","name":"Rhythm Pharmaceuticals Inc.","nameEN":"Rhythm Pharmaceuticals Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Rhythm Pharmaceuticals Inc.(RYTM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Rhythm Pharmaceuticals Inc.(RYTM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Rhythm Pharmaceuticals Inc.,RYTM,Rhythm Pharmaceuticals Inc.股票,Rhythm Pharmaceuticals Inc.股票老虎,Rhythm Pharmaceuticals Inc.股票老虎国际,Rhythm Pharmaceuticals Inc.行情,Rhythm Pharmaceuticals Inc.股票行情,Rhythm Pharmaceuticals Inc.股价,Rhythm Pharmaceuticals Inc.股市,Rhythm Pharmaceuticals Inc.股票价格,Rhythm Pharmaceuticals Inc.股票交易,Rhythm Pharmaceuticals Inc.股票购买,Rhythm Pharmaceuticals Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Rhythm Pharmaceuticals Inc.(RYTM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Rhythm Pharmaceuticals Inc.(RYTM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}